Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumour markers

H S Pandha1, J Waxman, K Sikora

  • 1Department of Clinical Oncology, Hammersmith Hospital, London.

British Journal of Hospital Medicine
|March 5, 1994
PubMed
Summary

Tumour markers, including cytogenetic markers and oncogenes, have greatly expanded their role in cancer management over the past decade. These advancements offer more specific diagnostic and monitoring capabilities for malignant diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer.

Oncogene·2026
Same author

COX2 Effects on endometrial carcinomas progression.

Pathology, research and practice·2022
Same author

How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

The Road Map for Proton Therapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2018
Same author

Heavy metals effect on breast cancer progression.

Journal of occupational medicine and toxicology (London, England)·2017

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • The past decade has witnessed significant growth in the application of tumour markers.
  • Tumour markers are increasingly vital in clinical oncology.

Purpose of the Study:

  • To highlight the expanded role of tumour markers in cancer diagnosis, prognosis, and monitoring.
  • To discuss the broadened definition of tumour markers, encompassing genetic and molecular indicators.

Main Methods:

  • Review of recent advancements in tumour marker technology and application.
  • Analysis of the integration of cytogenetic markers, oncogenes, and oncogene products.

Main Results:

  • Tumour markers now play a crucial role in diagnosis, localization, prognosis, staging, and monitoring of malignancies.
  • The expanded definition allows for more specific and effective cancer detection and management strategies.

Conclusions:

  • The evolving landscape of tumour markers, including molecular and genetic markers, enhances the precision of cancer care.
  • Further development of these markers promises improved patient outcomes in managing malignant diseases.

Related Experiment Videos